About Adcentrx Therapeutics

Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.

Management team


Dr. Hui Li

President and CEO

Dr. Hui Li is the President and CEO of Adcentrx Therapeutics with over 20 years of drug discovery and business development experience in the biotech and pharmaceutical industry.
Read More


Dr. Pia Challita-Eid

Chief Scientific Officer

Dr. Pia Challita-Eid serves as the Chief Scientific Officer at Adcentrx Therapeutics. She brings over 20 years of experience in the biotechnology industry, contributing to the discovery and progression into the clinic of over 12 drug candidates including the FDA-approved product Padcev™.
Read More


Dr. Alexander Chu-Kung

Vice President, CMC

Alexander Chu-Kung is the Vice President of CMC at Adcentrx Therapeutics. Prior to joining Adcentrx, Dr Chu-Kung was the Senior Director of Development at Levena Biopharma, a subsidiary of Sorrento Therapeutics where he was responsible for all aspects of process development, cGMP manufacturing and clinical supply of the antibody drug conjugate pipeline.
Read More